30 closest matches · ranked by relevance
Osteoporosis · Obesity · Weight Loss
Primary: Bone Mineral Density-Total Body — -0.3; -1.1 percent change in BMD (g/cm2) — p=<0.05
Healthy Participants
Primary: The Maximum Observed Concentration of Nirmatrelvir in Breast Milk Over the Dosing Interval — 1904 Nanograms / milliliter (ng/mL)
Vulvovaginal Candidiasis · Candida Infection · Vaginal Candidiasis
Primary: SCY-078 Breast Milk Concentrations. — 0; 37.64; 72.22; 43.85 ng/mL
Osteoporosis
Primary: Change in Bone Mineral Density (BMD) in HIP at 6 Months — -0.041; 0.011 grams/cm^2
Mastitis
Primary: Evidence of Clinically Definite Mastitis Confirmed by Microbiological Cultures and Somatic Cell Counts — 3.09; 2.90 log10 CFU/mL
Postpartum Contraception
Primary: Breastfeeding — 10; 9 participants
Vitamin D Deficiency
Primary: 25-Hydroxyvitamin D Levels for Postpartum Mother 7 Months After Delivery — 28.5; 38.0; 55.6 ng/mL
Docosohexaenoic Acid Supplementation of Mothers to
Primary: Infant Serum Soluble Receptor for AGE (sRAGE) Levels at 4 Weeks From Baseline From Mothers Supplemented With 200 or 1000 mg/kg Per Day of DHA — 900; 1127 pg/mL
Breastfeeding · Weight Loss
Primary: Number of Participants Still Breastfeeding at 20 Weeks Postpartum — 9; 8 Participants
Weight Loss · Diet Modification · Obesity
Primary: Feasibility of Recruitment — 22; 19 participants
Healthy Lactating Women
Primary: Area Under the Curve From Time Zero to End of Dosing Interval (AUCtau) — 32.50 microgram*hour/milliliter (mcg*hr/mL)
Breast Milk Expression
Primary: Pumped Milk Volume Day 1 — 3; 4; 5 mL — p=0.015
Low Milk Supply · Pre-diabetes · Insulin Resistance
Primary: Peak Change in Milk Output — 8; -58 milliliters
Breast Feeding
Primary: Perception of Milk Supply — 54.9; 56.2 score on a scale — p=.272
Healthy
Primary: Galactorrhea — 0; 56 percentage of participants
Iron-deficiency · Pregnancy Anemia · Obesity
Primary: Recruitment Feasibility — 10 percentage eligible and enrolled
Human Milk Microbiome · Bacterial Growth
Primary: Bacterial Community Richness — 64.2; 58.9; 64.0; 60.8 Observed taxa — p=0.9
Breastfeeding
Primary: Number of Participants Breastfeeding Without Formula Supplementation — 30; 30 Participants
Breastfeeding · Intention · Health Behavior
Primary: Number of Participants Who Intended to Exclusively Breastfeed Post-intervention — 40; 36; 86; 67 Participants
Mental Health Issue · Hiv · Breastfeeding, Exclusive
Primary: Maternal Mental Health — 8.5; 6.5; 3.0; 3.0 score on a scale
Late Preterm Infant
Primary: Phone Call Completion Rate — 194; 102; 59; 52 calls
Low Birthweight · Pre-Term
Primary: Length-for-Age Z-score — -1.43 Z-score
Jaundice · Breastfeeding
Primary: Number of Participants Exclusively Breastfeeding at 3 Months, or 3 Months Corrected if the Infant Was Born Prematurely — 22; 24 Participants — p=0.40
Healthy Lactating Women
Primary: Daily Infant Dose — 0.0331; 0.0337; 0.0002 Milligrams per day
Breastfeeding
Primary: Breastfeeding Exclusivity — 67; 84 Participants — p=.1200
Ketamine · Lactation
Primary: Ketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of .5mg/kg Ketamine — 51.2; 22.6; 10.6; 4.5 ng/mL
Influenza
Primary: Number of Participants Reporting Serious Adverse Events (SAEs) — 1; 0; 2; 1 participants
Bacterial Vaginosis
Primary: Safety of LACTIN-V in Healthy Pre-menopausal Women. — 0; 0; 0; 0 participants
Breast Feeding
Primary: Change in Total Adipose Tissue Volume — 0.718; 0.901; 0.775 Litres
Breastfeeding
Primary: Infant Feeding Status: Exclusive Breastfeeding — 46; 39 Participants